Gris-PEG (Pedinol Pharmacal, Inc.)


Welcome to the PulseAid listing for the Gris-PEG drug offered from Pedinol Pharmacal, Inc.. This Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Pedinol Pharmacal, Inc.
NON-PROPRIETARY NAME: griseofulvin
SUBSTANCE NAME: GRISEOFULVIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-07-26
END MARKETING DATE: 0000-00-00


Gris-PEG HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGris-PEG from Pedinol Pharmacal, Inc.
LABELER NAME: Pedinol Pharmacal, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 125(mg/1)
START MARKETING DATE: 2016-07-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0884-0763_d3d67926-0727-496e-b54c-d6c8770f84d6
PRODUCT NDC: 0884-0763
APPLICATION NUMBER: NDA050475

Other GRISEOFULVIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Griseofulvin
Cipla USA Inc.grisofulvin
CorePharma, LLCUltramicrosize Griseofulvin
Oceanside PharmaceuticalsGriseofulvin
Pedinol Pharmacal, Inc.Gris-PEG
Physicians Total Care, Inc.Griseofulvin
Qualitest PharmaceuticalsGriseofulvin
Rebel Distributors CorpGriseofulviin (microsize)
RiconPharma LLC.Ultramicrosize Griseofulvin
Rising Pharmaceuticals Inc.Griseofulvin
Rising Pharmaceuticals, IncGriseofulvin
Sandoz IncGriseofulvin
State of Florida DOH Central PharmacyGris-PEG